Belay Announces Update to NCCN Guidelines to Recommend CSF-based Genomic Profiling in Biopsy Infeasible High-Grade Gliomas

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) regarding characterization and treatment of central ...
Time

A Blood Test for Alzheimer's Disease Is Almost Here

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Targeted Oncology

NCCN Now Backs CSF Genomic Testing in Gliomas When Biopsy Isn't Possible

NCCN now endorses CSF-based profiling for biopsy-infeasible HGG/GBM to enable molecular characterization required for ...
Yahoo

FDA Approves First-Ever Blood Test for Alzheimer's—Here's What We Know

Add Yahoo as a preferred source to see more of our stories on Google. As of 2023, an estimated 6.7 million Americans aged 65 and older were living with Alzheimer’s disease, according to the ...
Medical Xpress

Investigators devise test to identify brain tumors from cerebrospinal fluid

Researchers with the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine and four other institutions have developed a molecular test to identify the presence of brain ...
Medical Xpress

Test detects brain cancers in cerebrospinal fluid with high accuracy

A novel, multi-analyte test developed by researchers at the Johns Hopkins Kimmel Cancer Center, its Ludwig Center and the Johns Hopkins Department of Neurosurgery can accurately identify brain cancers ...